Q3 2025 Earnings Call November 6, 2025 5:00 PM ESTCompany ParticipantsDorian LeBlanc - Chief Financial OfficerGeorge ...
The senior flautist, who has done his research in the structural evolution of the instrument, talks about the spiritual, ...
Surgery may be an option to manage ulcerative colitis when treatment with medication and lifestyle changes isn’t effective, ...
The FDA has approved Boehringer Ingelheim's nerandomilast as a treatment for idiopathic pulmonary fibrosis (IPF), giving the company a successor to its blockbuster therapy Ofev. Phosphodiesterase (PDE ...